New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series ...
Digital therapeutics company GAIA has announced the signing of a licensing agreement for attexis with fellow German firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback